Price
Nasal card and overall starting headline align at $144
Bottle details
Confirm volume and concentration
Care
Provider review required; complete inclusions need confirmation

The route attached to the $144 headline

Shed's nasal-spray card lists a starting price of $144 per month and a one-month supply. That is the lowest route-specific price on the checked NAD+ page. The injection and oral tablet cards each start at $169 per month, so the nasal figure should remain attached to this particular product when readers compare the provider's offers.

The page describes a prescribed, compounded preparation within an online care pathway. A visible price does not guarantee that the product is suitable or available for every applicant. We have not completed the clinical review, received a bottle or tested the delivery experience, and the exact prescription still needs confirmation.

A monthly supply is not a full bottle specification

The public card does not establish a standard volume and concentration for every nasal order. Request those details from the provider and pharmacy before comparing the offer with another brand that publishes a 15 mL bottle or a particular concentration. A monthly label alone does not establish equal quantities across different prescriptions.

Nor can the quantity be used to infer an absorbed dose or equivalence to an injection. Nasal delivery is a distinct route whose clinical evidence should be evaluated separately. Avoid treating the absence of needles as proof that the finished preparation has a better safety profile or produces the same results as an injectable product.

Budget for the whole care arrangement

The provider describes online assessment, pharmacy fulfillment and support through its portal. Ask whether the quoted $144 starting offer includes all necessary consultation, shipping and follow-up for the selected plan. Any additional testing or service should be identified explicitly rather than assumed to be included because the headline is expressed per month.

Confirm the renewal amount, payment interval and deadline for stopping another order. A one-month supply description does not establish the complete subscription agreement or the refund conditions after fulfillment. Keep those terms specific to NAD+ instead of applying weight-loss promotions or guarantees that may appear elsewhere in Shed's broader storefront.

Evaluate claims and practical handling together

Shed's page discusses NAD+ in relation to energy and normal cellular processes. We did not independently verify the marketed effects for this nasal formulation or establish a direct comparison with its injection and tablet products. The clinician should explain what evidence supports the proposed purpose, along with the limitations of that evidence for the individual situation.

Compounded medication is not FDA-approved, as the provider discloses. Obtain pharmacy-specific storage and beyond-use instructions, plus a contact for delivery and clinical concerns. The documented $144 starting price and stated month of supply make the offer identifiable; a meaningful decision still needs the complete bottle specification, payment terms and an assessment of suitability rather than an assumption that the cheapest route is the best clinical choice.

Sources & further reading

Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.

  1. Shed: injection, nasal and oral NAD+ offers Provider
  2. FDA: Compounding questions and answers Regulator